Replies to post #48668 on Medizone Intl. (fka MZEIQ)

[jackcross18]

The only fact that matters was the company was viable before Marshall filed the Chapter 11 petition. Maybe they would have gone bankrupt in January 2018, that's 6 months away. He couldn't give new management 6 months to prove itself, after his 20 years of failure.

Marshall squandered MZEI assets for over 20 years, from filing lawsuits against the Utah boys to renting office space that was never used. Shannon publically stated he wasn't concerned about making money.

These are the main two reasons shareholders are in the bind we are today. We know Marshall doesn't give a hoot about the individuals who funded his lifestyle for the past 20 years. The only question is:Does Shannon care ?

BTW shareholders will probably get nothing in either Chapter 7 or 11. The only hope is for someone (Shannon) to throw shareholders a bone through Chapter 11.

[fcmboca]

I find the last few posts by BenK, Ferrot, and Jackcross interesting but missing many very important details.

First of all, at the time the Dodd group entered the picture I would expect that they did their due diligence about the financial condition as well as the potential for the AsepticSure device . There is an obvious need for effective disinfection for hospitals, and other sites as current methods are supposedly not as effective as this method with its related chemicals.

The Marshalls along with Shannon had for several years attempted to complete development of the product and have it operational in a number of sites including hospital sites as well as in other environments. However they screwed up their relationships with these prospects many-many times and could not get the results that they promoted, like effectiveness and the time it took to disinfect in a real world environment. The product is still not ready for commercialization as I understand, and the upcoming FDA meeting is to determine the protocols that would be necessary for final approval as a medical device and not a final approval.

The Dodd group had accomplished a great deal of progress to move toward commercialization including establishing relationships with "partners" to work with for testing in real environments, and for "partners" for manufacturing the device and "partners" who were going to be distributors experienced in marketing to huge hospital and medical associations and buying groups. Just refer to the reports Dodd directed publically to existing shareholders that reported what they were doing. None of this had been accomplished by Marshall and Shannon over the years successfully on an ongoing basis. All of this was accomplished on a "shoestring" as Medizone was basically short on funds. Dodd then went forward and raised some immediate funds from institutional investors to move forward to a point where they had a commitment to proceed with a (S-1) private offering to these investors. Dodd was careful to have inserted into the agreement a provision preventing a "pump and dump" provision to prevent the investors from shorting the stock in the open market then covering their short with the option stock to protect the existing shareholders. They also had to disclose the financial risk to the investors as required by the lawyers and accountants otherwise they would have committed a fraud on the investors. Full disclosure of "risk factors" must be in a prospectus. Then the Marshall's "pulled the plug" by filing the Chapter 11 hoping to recapture the company for themselves to the detriment of all the stockholders. If anyone thinks that they can in 90 days obtain FDA approvals which would require on site testing for likely 9 months or more for this sum that must believe in "fairy dust".

My opinion is that their scheme is to invest the $200,000 which would have done nothing but make them preferred creditors and then get Medizone all for themselves. Screw the investors once again. It is hard to imaging how all these long suffering investors for years can believe anything that Marshall says at this point. It is hard to believe that they have conned the Trustee about there scheme and that he is not doing his due diligence about the state of the product and how the Marshalls could be using this scheme to take back the company using the $200 K with Shannon who is getting $20 K a month for the 3 months $60 K for the period . Sounds like a good "gig" or is he a co-conspirator?

I had recommended that you look at the LINKEDIN.COM website for Dodd and the people that he hired and you will see success after success in senior management positions with many public and private companies as you will see how you were screwed again by the Marshalls.

SEROLOGICALS CORPORATION-DAVID DODD
President, CEO & Director
June 2000 - July 2006 6 Yrs 2 Mo
Atlanta GA and multiple operating locations worldwide
NASDAQ "SERO" Dodd transformed the Company valued at $80 million in June 2000 to an all-cash acquisition value of $1.5 billion by Millipore Corporation in July 2006

SOLVAY PHARMACEUTICALS (Subsidiary of Unimed Pharma)
David Dodd CEO, President & Director
August 1995 - June 2000
Atlanta GA. During Mr Dodds service Net Sales grew from $100 million in 1994 to $550 million in 2000. Enterprise Value increased from $100 million to $2.5 billion

BioReliance Corporation
David Dodd President, CEO, & Chairman
December 2007 - June 2009
Rockville, Md.
Company was acquired from Invitrogen Corp in April 2007 for $210 million. Mr Dodd was co-investor responsible for re-establishing BioReliance as an independent operating company with revenues of $115 million. Company was acquired by Sigma-Aldrich in all cash transaction for $350 million

There are many more successful engagements for Mr.Dodd listed on LINKEDIN.COM check it out for yourselves and see again how you got screwed by Ed and Jill Marshall.